This site is intended for health professionals only

At the heart of general practice since 1960

Read the latest issue online

Gold, incentives and meh

Report this comment to a moderator

Please fill in the form below if you think a comment is unsuitable. Your comments will be sent to our moderator for review.

Report comment to moderator

Required fields.


Consider stopping treatment with 'limited benefit' in multimorbidity, advises NICE


These guidelines are very welcome and long overdue. Yes, reviewing treatment plans, tailoring treatment plans and reducing treatments of limited benefit may take some initial extra time but the long-term payoff may come with reduced appointments from patients complaining of what are essentially drug side-effects or multi-drug interactions.

Posted date

21 Sep 2016

Posted time